ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,541, issued on Aug. 12, was assigned to Incyte Corp. (Wilmington, Del.).
"ALK2 inhibitors for the treatment of anemia" was invented by Francis Seguy (Lausanne, Switzerland), Ekaterine Asatiani (Founex, Switzerland) and Yaoyu Chen (Newark, Del.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods of treating anemia in a subject in need thereof comprising administering to the subject a therapeutically effective amount of an ALK2 inhibitor."
The patent was filed on June 28, 2023, under Application No. 18/343,267.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parse...